应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00853 微创医疗
交易中 11-18 13:25:46
6.190
+0.010
+0.16%
最高
6.300
最低
6.120
成交量
311.63万
今开
6.300
昨收
6.180
日振幅
2.91%
总市值
113.58亿
流通市值
113.58亿
总股本
18.35亿
成交额
1,929万
换手率
0.17%
流通股本
18.35亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
微创医疗(00853)下跌5.12%,报6.3元/股
金融界 · 11-13
微创医疗(00853)下跌5.12%,报6.3元/股
微创医疗盘中异动 股价大跌5.12%报6.300港元
市场透视 · 11-13
微创医疗盘中异动 股价大跌5.12%报6.300港元
港股午评|恒生指数早盘跌1.73% 医疗器械股走高
智通财经 · 11-12
港股午评|恒生指数早盘跌1.73% 医疗器械股走高
微创医疗盘中涨近8% 小摩上调公司长期净利润率预测
新浪港股 · 11-12
微创医疗盘中涨近8% 小摩上调公司长期净利润率预测
港股异动 | 微创医疗(00853)盘中涨近8% 心脉医疗前三季度纯利增超42% 小摩上调公司长期净利润率预测
智通财经 · 11-12
港股异动 | 微创医疗(00853)盘中涨近8% 心脉医疗前三季度纯利增超42% 小摩上调公司长期净利润率预测
港股异动 | 医疗器械股走高 医保预付金有望推动企业回款加速 创新器械将迎新放量空间
智通财经 · 11-12
港股异动 | 医疗器械股走高 医保预付金有望推动企业回款加速 创新器械将迎新放量空间
港股概念追踪 |两部门:做好医保基金预付工作 药械迎医院回款全面解决(附概念股)
智通财经 · 11-12
港股概念追踪 |两部门:做好医保基金预付工作 药械迎医院回款全面解决(附概念股)
微创医疗(00853)上涨5.01%,报6.92元/股
金融界 · 11-12
微创医疗(00853)上涨5.01%,报6.92元/股
微创医疗盘中异动 大幅拉升5.01%
市场透视 · 11-12
微创医疗盘中异动 大幅拉升5.01%
小摩:予微创医疗“增持”评级 目标价升至7.8港元
智通财经网 · 11-11
小摩:予微创医疗“增持”评级 目标价升至7.8港元
小摩:予微创医疗(00853)“增持”评级 目标价升至7.8港元
智通财经网 · 11-11
小摩:予微创医疗(00853)“增持”评级 目标价升至7.8港元
《大行》摩通升微创医疗(00853.HK)目标价至7.8元 评级“增持”
阿斯达克财经 · 11-11
《大行》摩通升微创医疗(00853.HK)目标价至7.8元 评级“增持”
南向资金11月7日净买入微创医疗18.46万股 连续3日增持
市场透视 · 11-08
南向资金11月7日净买入微创医疗18.46万股 连续3日增持
南向资金11月4日净卖出微创医疗105.45万股 连续3日减持
市场透视 · 11-05
南向资金11月4日净卖出微创医疗105.45万股 连续3日减持
微创医疗10月30日遭主力抛售379万元 环比增加104.86%
市场透视 · 10-30
微创医疗10月30日遭主力抛售379万元 环比增加104.86%
异动解读 | 微创医疗附属心脉医疗科技业绩欠佳 引发股价5%跳水
异动解读 · 10-30
异动解读 | 微创医疗附属心脉医疗科技业绩欠佳 引发股价5%跳水
微创医疗盘中异动 股价大跌5.04%报6.410港元
市场透视 · 10-30
微创医疗盘中异动 股价大跌5.04%报6.410港元
微创医疗:心脉医疗科技前三季归母净利润约5.53亿元 同比增长42.46%
新浪港股 · 10-30
微创医疗:心脉医疗科技前三季归母净利润约5.53亿元 同比增长42.46%
微创医疗(00853.HK)附属心脉医疗科技首九个月赚5.53亿人民币 增长42.5%
阿斯达克财经 · 10-30
微创医疗(00853.HK)附属心脉医疗科技首九个月赚5.53亿人民币 增长42.5%
微创医疗(00853):心脉医疗科技前三季归母净利约5.53亿元,同比增长42.46%
智通财经网 · 10-29
微创医疗(00853):心脉医疗科技前三季归母净利约5.53亿元,同比增长42.46%
加载更多
公司概况
公司名称:
微创医疗
所属市场:
SEHK
上市日期:
--
主营业务:
微创医疗科学有限公司是一家主要从事医疗产品制造及销售业务的香港投资控股公司。该公司主要通过七大分部运营。骨科医疗器械分部研究、开发、制造及销售骨科医疗器械。心血管介入产品分部研究、开发、生产及销售心血管用器械,如:药物洗脱支架。大动脉与外周介入产品分部研究、开发、生产及销售大动脉及外周血管介入产品。电生理医疗器械分部研究、开发、制造及销售电生理医疗器械。神经介入产品分部研究、开发、生产及销售神经介入产品。外科医疗器械分部研究、开发、制造及销售外科手术器械。糖尿病及内分泌医疗器械分部研究、开发、制造及销售糖尿病相关器械。
发行价格:
--
{"stockData":{"symbol":"00853","market":"HK","secType":"STK","nameCN":"微创医疗","latestPrice":6.19,"timestamp":1731907436908,"preClose":6.18,"halted":0,"volume":3116270,"delay":0,"floatShares":1834940193,"shares":1834940193,"eps":-2.038613,"marketStatus":"交易中","marketStatusCode":2,"change":0.01,"latestTime":"11-18 13:25:46","open":6.3,"high":6.3,"low":6.12,"amount":19292540,"amplitude":0.029126,"askPrice":6.19,"askSize":6100,"bidPrice":6.18,"bidSize":21900,"shortable":3,"etf":0,"ttmEps":-1.8166425335139427,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1731917400000},"adr":0,"adjPreClose":6.18,"dividendRate":0.007019,"openAndCloseTimeList":[[1731893400000,1731902400000],[1731906000000,1731916800000]],"volumeRatio":0.438841,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00853","defaultTab":"news","newsList":[{"id":"2483130930","title":"微创医疗(00853)下跌5.12%,报6.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483130930","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483130930?lang=zh_cn&edition=full","pubTime":"2024-11-13 10:26","pubTimestamp":1731464767,"startTime":"0","endTime":"0","summary":"11月13日,微创医疗(00853)盘中下跌5.12%,截至10:26,报6.3元/股,成交4157.78万元。微创医疗科学有限公司主要从事高端医疗器械的研发、生产和销售,业务包含心血管、脑血管神经调控、大血管生命支持与外周、电生理及心律管理、医疗机器人、妇科泌尿科消化科、关节脊柱创伤运动医学、眼科呼吸道、癌症治疗、内分泌诊断、再生医学、整容塑形等多个领域。该公司的产品已应用于全球100多个国家的两万家医院中,平均每5秒便有一个微创的产品用于挽救或延长生命、提升生命品质。截至2024年中报,微创医疗营业总收入39.82亿元、净利润-6.9亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/13102645231750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1585","00853","BK1100","BK1589"],"gpt_icon":0},{"id":"2483015186","title":"微创医疗盘中异动 股价大跌5.12%报6.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483015186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483015186?lang=zh_cn&edition=full","pubTime":"2024-11-13 10:26","pubTimestamp":1731464764,"startTime":"0","endTime":"0","summary":"2024年11月13日早盘10时26分,微创医疗股票出现异动,股价大幅跳水5.12%。截至发稿,该股报6.300港元/股,成交量644.82万股,换手率0.35%,振幅5.87%。资金方面,该股资金流入1096.93万港元,流出2522.77万港元。微创医疗股票所在的医疗设备及用品行业中,整体跌幅为0.12%。其相关个股中,巨星医疗控股、健世科技-B、加和国际控股涨幅较大,振幅较大的相关个股有高视医疗、巨星医疗控股、智云健康,振幅分别为10.26%、8.22%、6.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113102604a2321862&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113102604a2321862&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00853","BK1583","BK1589","BK1585","BK1100"],"gpt_icon":0},{"id":"2482717882","title":"港股午评|恒生指数早盘跌1.73% 医疗器械股走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2482717882","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482717882?lang=zh_cn&edition=full","pubTime":"2024-11-12 12:00","pubTimestamp":1731384043,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,恒生指数早盘跌1.73%,报200073点;恒生科技指数跌2.25%。医疗器械股走高。医保预付金有望推动企业回款加速,创新器械将迎新放量空间。海吉亚医疗早盘涨超12.31%,医保预付金制度落地,医疗机构资金压力有望缓解。双11家电市场迎消费热潮,以旧换新有望驱动四季度回暖。耐世特涨6.52%,特朗普新政下燃油车业务有望回暖,自动驾驶稳步发展。港股内房股普跌,世茂集团跌超1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209680.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02252","00853","BK1585","BK1222","BK1574","MCHmain","BK1583","YANG","HSCEI","159883","09997","513600","02172","BK1589","09996","HSTECH","02833","BK1100","HHImain","HSI"],"gpt_icon":1},{"id":"2482068714","title":"微创医疗盘中涨近8% 小摩上调公司长期净利润率预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2482068714","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482068714?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:52","pubTimestamp":1731383520,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 微创医疗(00853)盘中涨近8%,截至发稿,股价上涨3.64%,现报6.83港元,成交额9777.65万港元。\n 微创医疗公布心脉医疗科技2024年前9个月业绩,收入约9.7亿元,同比增长9.13%;归属于心脉医疗科技股权持有人的净利润约5.53亿元,同比增长42.46%。\n 小摩发表报告指,在微创医疗附属心脉医疗公布第三季业绩发表后,将母企微创医疗H股目标价由7.5元升至7.8元,评级“增持”。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-12/doc-incvupap6489614.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-12/doc-incvupap6489614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00853"],"gpt_icon":0},{"id":"2482145547","title":"港股异动 | 微创医疗(00853)盘中涨近8% 心脉医疗前三季度纯利增超42% 小摩上调公司长期净利润率预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2482145547","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482145547?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:41","pubTimestamp":1731382869,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,微创医疗盘中涨近8%,截至发稿,涨4.1%,报6.86港元,成交额9627.74万港元。消息面上,微创医疗公布心脉医疗科技2024年前9个月业绩,收入约9.7亿元,同比增长9.13%;归属于心脉医疗科技股权持有人的净利润约5.53亿元,同比增长42.46%。不过,该行指心脉医疗改善营运效率方面的努力将有助长期利润率,将长期净利润率预测由23%大幅上调至约30%。因此,该行亦相应上调微创医疗长期净利润率预测,由原先11%向上修订至12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209673.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688016","00853"],"gpt_icon":0},{"id":"2482194007","title":"港股异动 | 医疗器械股走高 医保预付金有望推动企业回款加速 创新器械将迎新放量空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2482194007","media":"智通财经","labels":["Business Data","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482194007?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:07","pubTimestamp":1731380835,"startTime":"0","endTime":"0","summary":"消息面上,11月11日,国家医保局办公室财政部办公厅印发《关于做好医保基金预付工作的通知》。药品和医用耗材集中带量采购医保基金专项预付按原规定执行。预付制度的逐步推进有望改善产业链的整体账期,其中流通企业受益较为直接,建议关注国药控股、上海医药、华润医药等;多元化支付结构的建立,将打开创新药、创新器械的新放量空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209659.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1585","00853","09997","BK1583","BK1500","BK1515","BK1574","BK1589","BK1222","01099","02607","02252","01858","159883","LU1115378108.SGD","LU0640798160.USD","BK1100","BK1197"],"gpt_icon":0},{"id":"2482436715","title":"港股概念追踪 |两部门:做好医保基金预付工作 药械迎医院回款全面解决(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482436715","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482436715?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:41","pubTimestamp":1731379281,"startTime":"0","endTime":"0","summary":"国家医保局办公室、财政部办公厅印发了《关于做好医保基金预付工作的通知》。《通知》从政策制度安排、申请流程、会计核算和监督等方面明确了规范要求,主要体现“三个明确”和“三个规范”。药品和医用耗材集中带量采购医保基金专项预付按原规定执行。基金安全是实施预付工作的基本前提,应坚持尽力而为、量力而行的原则。药械企业回款难问题解决已迫在眉睫。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSCEI","00853","02172","BK1583","HSTECH","BK1585","02252","BK1100","YANG","BK1589"],"gpt_icon":1},{"id":"2482141790","title":"微创医疗(00853)上涨5.01%,报6.92元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482141790","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482141790?lang=zh_cn&edition=full","pubTime":"2024-11-12 09:57","pubTimestamp":1731376672,"startTime":"0","endTime":"0","summary":"11月12日,微创医疗(00853)盘中上涨5.01%,截至09:57,报6.92元/股,成交1993.22万元。微创医疗科学有限公司主要从事高端医疗器械的研发、生产和销售,业务包含心血管、脑血管神经调控、大血管生命支持与外周、电生理及心律管理、医疗机器人、妇科泌尿科消化科、关节脊柱创伤运动医学、眼科呼吸道、癌症治疗、内分泌诊断、再生医学、整容塑形等多个领域。该公司的产品已应用于全球100多个国家的两万家医院中,平均每5秒便有一个微创的产品用于挽救或延长生命、提升生命品质。截至2024年中报,微创医疗营业总收入39.82亿元、净利润-6.9亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/12095745179415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1100","BK1583","00853","BK1589","BK1585"],"gpt_icon":0},{"id":"2482370718","title":"微创医疗盘中异动 大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482370718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482370718?lang=zh_cn&edition=full","pubTime":"2024-11-12 09:57","pubTimestamp":1731376670,"startTime":"0","endTime":"0","summary":"2024年11月12日早盘09时57分,微创医疗股票出现异动,股价大幅上涨5.01%。微创医疗股票所在的医疗设备及用品行业中,整体涨幅为0.07%。消息层面,截至09时57分,《小摩:予微创医疗“增持”评级 目标价升至7.8港元》资讯为影响微创医疗的重要信息。因此,该行亦相应上调微创医疗长期净利润率预测,由原先11%向上修订至12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112095750971a5dab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112095750971a5dab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00853","BK1583","BK1585","BK1589","BK1100"],"gpt_icon":0},{"id":"2482724456","title":"小摩:予微创医疗“增持”评级 目标价升至7.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482724456","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482724456?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:50","pubTimestamp":1731293420,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,小摩发布研究报告称,在微创医疗附属心脉医疗公布第三季业绩发表后,将母企微创医疗H股目标价由7.5港元升至7.8港元,评级“增持”。不过,该行指心脉医疗改善营运效率方面的努力将有助长期利润率,将长期净利润率预测由23%大幅上调至约30%。因此,该行亦相应上调微创医疗长期净利润率预测,由原先11%向上修订至12%。该行维持认为微创医疗可以达成2024至2026年主要经营目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111105408a22af3d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111105408a22af3d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00853"],"gpt_icon":0},{"id":"2482249388","title":"小摩:予微创医疗(00853)“增持”评级 目标价升至7.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482249388","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482249388?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:50","pubTimestamp":1731293420,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,小摩发布研究报告称,在微创医疗附属心脉医疗公布第三季业绩发表后,将母企微创医疗H股目标价由7.5港元升至7.8港元,评级“增持”。不过,该行指心脉医疗改善营运效率方面的努力将有助长期利润率,将长期净利润率预测由23%大幅上调至约30%。因此,该行亦相应上调微创医疗长期净利润率预测,由原先11%向上修订至12%。该行维持认为微创医疗可以达成2024至2026年主要经营目标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209070.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["00853"],"gpt_icon":0},{"id":"2482439412","title":"《大行》摩通升微创医疗(00853.HK)目标价至7.8元 评级“增持”","url":"https://stock-news.laohu8.com/highlight/detail?id=2482439412","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482439412?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:52","pubTimestamp":1731289920,"startTime":"0","endTime":"0","summary":"摩通发表报告指,在微创医疗附属心脉医疗公布第三季业绩发表后,将母企微创医疗H股目标价由7.5元升至7.8元,评级“增持”。不过,该行指心脉医疗改善营运效率方面的努力将有助长期利润率,将长期净利润率预测由23%大幅上调至约30%。因此,该行亦相应上调微创医疗长期净利润率预测,由原先11%向上修订至12%。该行维持认为微创医疗可以达成2024至2026年主要经营目标。该行提及,管理层曾承诺今明两年收窄亏损,2026年有望扭亏赚9,000万美元。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180125102119777_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180125102119777_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1395545/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00853"],"gpt_icon":0},{"id":"2481169933","title":"南向资金11月7日净买入微创医疗18.46万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2481169933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481169933?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:30","pubTimestamp":1731029410,"startTime":"0","endTime":"0","summary":"11月7日, 南向资金增持微创医疗18.46万股,连续3日增持。截止当日收盘,港股通共持有微创医疗62429.38万股,占流通股33.80%。微创医疗近5个交易日上涨5.59%,港股通累计减持198.04万股;近20个交易日下跌7.23%,港股通累计增持3698.28万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108093040a2222016&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108093040a2222016&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1589","00853","BK1583","BK1100"],"gpt_icon":0},{"id":"2481591188","title":"南向资金11月4日净卖出微创医疗105.45万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2481591188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481591188?lang=zh_cn&edition=full","pubTime":"2024-11-05 09:30","pubTimestamp":1730770210,"startTime":"0","endTime":"0","summary":"11月4日,南向资金减持微创医疗105.45万股连续3日减持。截止当日收盘,港股通共持有微创医疗62380.63万股,占流通股33.99%。港股通减持金额前五个股分别为美团-W、吉利汽车、比亚迪股份、中国海洋石油、工商银行。微创医疗近5个交易日下跌4.59%,港股通累计减持134.88万股;近20个交易日下跌25.95%,港股通累计增持4936.31万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105093054a2165cfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105093054a2165cfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1583","BK1589","00853","BK1585"],"gpt_icon":0},{"id":"2479221656","title":"微创医疗10月30日遭主力抛售379万元 环比增加104.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479221656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479221656?lang=zh_cn&edition=full","pubTime":"2024-10-30 16:16","pubTimestamp":1730276188,"startTime":"0","endTime":"0","summary":"10月30日, 微创医疗股价跌1.48%,报收6.65元,成交金额7002万元,换手率0.58%,振幅5.93%,量比0.90。微创医疗今日主力资金净流出379万元,连续3日净流出,上一交易日主力净流出185万元,今日环比增加104.86%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为25.00%,平均跌幅为4.66%。该股近5个交易日上涨0.90%,主力资金累计净流入1142万元;近20日主力资金累计净流出5567万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030161710a1f90365&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030161710a1f90365&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1100","BK1585","00853","BK1583"],"gpt_icon":0},{"id":"1148120872","title":"异动解读 | 微创医疗附属心脉医疗科技业绩欠佳 引发股价5%跳水","url":"https://stock-news.laohu8.com/highlight/detail?id=1148120872","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148120872?lang=zh_cn&edition=full","pubTime":"2024-10-30 13:30","pubTimestamp":1730266248,"startTime":"0","endTime":"0","summary":"10月30日,微创医疗股价盘中大跌5.04%,报6.41港元。作为微创医疗重要附属公司,心脉医疗科技业绩表现不理想,令市场对微创医疗整体前景的信心受到冲击,从而引发股价大幅下跌。值得注意的是,微创医疗旗下其他产品线表现如何,对其股价影响亦不可小视。市场正在密切关注微创医疗2024年前三季度整体业绩情况,以便更全面评估公司基本面。分析指出,随着后续年报等信息披露,公司股价走势或将趋稳。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 微创医疗附属心脉医疗科技业绩欠佳 引发股价5%跳水","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["00853"],"gpt_icon":0},{"id":"2479389243","title":"微创医疗盘中异动 股价大跌5.04%报6.410港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479389243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479389243?lang=zh_cn&edition=full","pubTime":"2024-10-30 13:18","pubTimestamp":1730265502,"startTime":"0","endTime":"0","summary":"2024年10月30日下午盘13时18分,微创医疗股票出现波动,股价急速跳水5.04%。截至发稿,该股报6.410港元/股,成交量625.77万股,换手率0.34%,振幅5.93%。资金方面,该股资金流入1101.07万港元,流出2503.07万港元。微创医疗股票所在的医疗设备及用品行业中,整体跌幅为0.13%。其相关个股中,君百延集团、高视医疗、华检医疗涨幅较大,振幅较大的相关个股有云能国际、巨星医疗控股、加和国际控股,振幅分别为65.33%、7.69%、7.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030131822971a3217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030131822971a3217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1583","BK1585","00853","BK1589"],"gpt_icon":0},{"id":"2479260429","title":"微创医疗:心脉医疗科技前三季归母净利润约5.53亿元 同比增长42.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479260429","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479260429?lang=zh_cn&edition=full","pubTime":"2024-10-30 07:55","pubTimestamp":1730246155,"startTime":"0","endTime":"0","summary":"微创医疗(00853)公布心脉医疗科技2024年前9个月业绩,收入约9.7亿元,同比增长9.13%;归属于心脉医疗科技股权持有人的净利润约5.53亿元,同比增长42.46%。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-30/doc-incuhrze1338029.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-30/doc-incuhrze1338029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["00853"],"gpt_icon":0},{"id":"2479258846","title":"微创医疗(00853.HK)附属心脉医疗科技首九个月赚5.53亿人民币 增长42.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479258846","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479258846?lang=zh_cn&edition=full","pubTime":"2024-10-30 02:25","pubTimestamp":1730226300,"startTime":"0","endTime":"0","summary":"微创医疗(00853.HK) 公布,附属心脉医疗科技首九个月业绩,实现收入9.7亿人民币(下同),按年增加9.1%。归属股东净利润5.53亿元,增长42.5%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-29 16:25。)过往派息公布日期派息事项派息内容2024/08/30中期业绩无派息2024/03/28末期业绩无派息2023/08/30中期业绩无派息2023/05/18特别报告优先发售:保证配额以优先发售微创心律管理有限公司股份AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180321104207082_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180321104207082_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1392146/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0251","688016","BK1100","BK1583","BK1589","00853","BK1585"],"gpt_icon":0},{"id":"2479640748","title":"微创医疗(00853):心脉医疗科技前三季归母净利约5.53亿元,同比增长42.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479640748","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479640748?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:04","pubTimestamp":1730207078,"startTime":"0","endTime":"0","summary":"智通财经APP讯,微创医疗(00853)公布心脉医疗科技2024年前9个月业绩,收入约9.7亿元,同比增长9.13%;归属于心脉医疗科技股权持有人的净利润约5.53亿元,同比增长42.46%。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1202886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","BK1100","00853","BK0251","BK1589","688016","BK1585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.microport.com.cn","stockEarnings":[{"period":"1week","weight":-0.0721},{"period":"1month","weight":-0.008},{"period":"3month","weight":0.1931},{"period":"6month","weight":-0.1271},{"period":"1year","weight":-0.5436},{"period":"ytd","weight":-0.266}],"compareEarnings":[{"period":"1week","weight":-0.0628},{"period":"1month","weight":-0.0424},{"period":"3month","weight":0.1145},{"period":"6month","weight":-0.0065},{"period":"1year","weight":0.0894},{"period":"ytd","weight":0.1395}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创医疗科学有限公司是一家主要从事医疗产品制造及销售业务的香港投资控股公司。该公司主要通过七大分部运营。骨科医疗器械分部研究、开发、制造及销售骨科医疗器械。心血管介入产品分部研究、开发、生产及销售心血管用器械,如:药物洗脱支架。大动脉与外周介入产品分部研究、开发、生产及销售大动脉及外周血管介入产品。电生理医疗器械分部研究、开发、制造及销售电生理医疗器械。神经介入产品分部研究、开发、生产及销售神经介入产品。外科医疗器械分部研究、开发、制造及销售外科手术器械。糖尿病及内分泌医疗器械分部研究、开发、制造及销售糖尿病相关器械。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.003149},{"month":2,"riseRate":0.428571,"avgChangeRate":0.00486},{"month":3,"riseRate":0.5,"avgChangeRate":0.021886},{"month":4,"riseRate":0.428571,"avgChangeRate":0.027977},{"month":5,"riseRate":0.571429,"avgChangeRate":0.030356},{"month":6,"riseRate":0.428571,"avgChangeRate":0.038173},{"month":7,"riseRate":0.5,"avgChangeRate":-0.0126},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.048949},{"month":9,"riseRate":0.571429,"avgChangeRate":0.024872},{"month":10,"riseRate":0.666667,"avgChangeRate":0.018452},{"month":11,"riseRate":0.466667,"avgChangeRate":0.012226},{"month":12,"riseRate":0.357143,"avgChangeRate":-0.019332}],"exchange":"SEHK","name":"微创医疗","nameEN":"MICROPORT"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微创医疗,00853,微创医疗股票,微创医疗股票老虎,微创医疗股票老虎国际,微创医疗行情,微创医疗股票行情,微创医疗股价,微创医疗股市,微创医疗股票价格,微创医疗股票交易,微创医疗股票购买,微创医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}